41 – 50 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease.
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - a possible new treatment?
(
- Contribution to journal › Published meeting abstract
-
Mark
Combination of Autoantibodies Against Different Histone Proteins Influences Complement-dependent Phagocytosis of Necrotic Cell Material by Polymorphonuclear Leukocytes in Systemic Lupus Erythematosus.
(
- Contribution to journal › Article
-
Mark
Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.
(
- Contribution to journal › Article
-
Mark
Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
(
- Contribution to journal › Article
-
Mark
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation
(
- Contribution to journal › Article
-
Mark
Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene
(
- Contribution to journal › Article
-
Mark
Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein
(
- Contribution to journal › Article
- 2011
-
Mark
Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.
(
- Contribution to journal › Article